The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Ent-4-amino-15-beta-hydroxymethyl-19-norbeyeran-16-alpha-ol ID: ALA4878837
PubChem CID: 164626249
Max Phase: Preclinical
Molecular Formula: C20H35NO2
Molecular Weight: 321.50
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: C[C@]12CC[C@H]3[C@]4(C)CCC[C@@](C)(N)[C@H]4CC[C@@]3(C1)[C@H](CO)[C@H]2O
Standard InChI: InChI=1S/C20H35NO2/c1-17-9-5-15-18(2)7-4-8-19(3,21)14(18)6-10-20(15,12-17)13(11-22)16(17)23/h13-16,22-23H,4-12,21H2,1-3H3/t13-,14+,15+,16-,17+,18-,19-,20-/m1/s1
Standard InChI Key: LOSUHMVZAVYESC-WWWUCTDISA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
32.6269 -19.3813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2141 -20.0939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0421 -20.0968 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.9145 -18.1458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9145 -18.9696 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6269 -17.7297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3393 -18.1458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3381 -18.9696 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0454 -19.3847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.7653 -18.9790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0521 -17.7330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.7665 -18.1585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.4850 -17.7532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.4988 -16.9241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.7844 -16.4987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0603 -16.9065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6219 -18.5599 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
34.0452 -18.5599 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
36.2188 -16.5200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3321 -17.3180 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.4779 -18.5686 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2106 -17.3330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.0095 -17.1238 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.8655 -19.2949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.7100 -19.3232 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 1
1 3 1 0
4 5 1 0
4 6 1 0
5 1 1 0
1 8 1 0
7 6 1 0
7 8 1 0
7 11 1 0
8 9 1 0
9 10 1 0
10 12 1 0
11 12 1 0
11 16 1 0
12 13 1 1
13 14 1 0
14 15 1 0
15 16 1 0
8 17 1 1
11 18 1 1
14 19 1 1
7 20 1 6
12 21 1 0
14 22 1 0
21 22 1 0
22 23 1 6
21 24 1 1
24 25 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 321.50Molecular Weight (Monoisotopic): 321.2668AlogP: 3.08#Rotatable Bonds: 1Polar Surface Area: 66.48Molecular Species: BASEHBA: 3HBD: 3#RO5 Violations: ┄HBA (Lipinski): 3HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 10.72CX LogP: 1.99CX LogD: -0.86Aromatic Rings: ┄Heavy Atoms: 23QED Weighted: 0.70Np Likeness Score: 2.44
References 1. Zhang H, Liu B, Xu G, Xu C, Ou E, Liu J, Sun X, Zhao Y.. (2021) Synthesis and in vivo screening of isosteviol derivatives as new cardioprotective agents., 219 [PMID:33862515 ] [10.1016/j.ejmech.2021.113396 ]